Bioadaptives annual operating margin
2022
2023
2024
2025
Bioadaptives's operating margin was −5,701.79% for fiscal 2025.
View full Bioadaptives company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −5,701.79% | −949.32 pp |
| 2024 | 2024-12-31 | −4,752.47% | −3951.06 pp |
| 2023 | 2023-12-31 | −801.40% | +1654.93 pp |
| 2022 | 2022-12-31 | −2,456.33% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −3,953.01% | +4721.08 pp |
| Q1 2026 | 2026-03-31 | −3,594.81% | +10179.71 pp |
| Q4 2025 | 2025-12-31 | −2,379.56% | −1964.09 pp |
| Q3 2025 | 2025-09-30 | −5,735.95% | −4877.95 pp |
| Q2 2025 | 2025-06-30 | −8,674.09% | −8084.83 pp |
| Q2 2024 | 2024-06-30 | −13,774.52% | −11382.51 pp |
| Q1 2024 | 2024-03-31 | −415.47% | +146.58 pp |
| Q4 2023 | 2023-12-31 | −857.99% | −637.69 pp |
| Q3 2023 | 2023-09-30 | −589.26% | — |
| Q2 2023 | 2023-06-30 | −2,392.01% | — |
| Q1 2023 | 2023-03-31 | −562.06% | — |
| Q3 2016 | 2016-09-30 | −220.30% | — |
Across the available reported history, Bioadaptives's operating margin decreased from −4,752.47% to −5,701.79%, a change of −949.32 percentage points. The latest reported quarter, Q2 2026, shows −3,953.01%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioadaptives filings at SEC.gov ↗